Literature DB >> 1360035

High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients.

R Y Wang1, J W Shih, T Grandinetti, P F Pierce, M M Hayes, D J Wear, H J Alter, S C Lo.   

Abstract

Mycoplasma penetrans, a novel mycoplasma isolated from HIV-1-infected patients with AIDS, has pathogenic properties associated with in-vivo virulence. Enzyme-linked immunosorbent assay and western blotting detected a more than 100 times higher frequency of antibodies to the mycoplasma in serum from HIV-1-infected patients with AIDS (40%) than from HIV-negative controls (0.3%). Serum from 20% of HIV-1-infected, symptom-free individuals also had M penetrans specific antibodies. The antibodies' major immunoreactivity was directed against P35 and P38, the two main lipid-associated membrane protein antigens of the organism. Patients attending sexually transmitted disease clinics had a low frequency of antibody (0.9%). None of 178 HIV-negative patients with different non-AIDS diseases, many associated with immune dysfunction and/or low white cell counts, tested positive for the antibodies. M penetrans, apparently not a commensal and not a simple opportunist, is uniquely associated with HIV-1 infection and AIDS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360035     DOI: 10.1016/0140-6736(92)92493-y

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

1.  The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans.

Authors:  Yuko Sasaki; Jun Ishikawa; Atsushi Yamashita; Kenshiro Oshima; Tsuyoshi Kenri; Keiko Furuya; Chie Yoshino; Atsuko Horino; Tadayoshi Shiba; Tsuguo Sasaki; Masahira Hattori
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Role of Mycoplasma penetrans endonuclease P40 as a potential pathogenic determinant.

Authors:  M Bendjennat; A Blanchard; M Loutfi; L Montagnier; E Bahraoui
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Multiple promoter inversions generate surface antigenic variation in Mycoplasma penetrans.

Authors:  Atsuko Horino; Yuko Sasaki; Tsuguo Sasaki; Tsuyoshi Kenri
Journal:  J Bacteriol       Date:  2003-01       Impact factor: 3.490

4.  Pathogenicity of Mycoplasma fermentans and Mycoplasma penetrans in experimentally infected chicken embryos.

Authors:  M M Hayes; B J Li; D J Wear; S C Lo
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation.

Authors:  S Tsai; D J Wear; J W Shih; S C Lo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

6.  In vitro influence of Mycoplasma penetrans on activation of peripheral T lymphocytes from healthy donors or human immunodeficiency virus-infected individuals.

Authors:  Y Sasaki; A Blanchard; H L Watson; S Garcia; A Dulioust; L Montagnier; M L Gougeon
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

7.  Detection of several Mycoplasma species at various anatomical sites of homosexual men.

Authors:  D Taylor-Robinson; C B Gilroy; F E Keane
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-07       Impact factor: 3.267

8.  Analysis of energy sources for Mycoplasma penetrans gliding motility.

Authors:  Dominika A Jurkovic; Michael R Hughes; Mitchell F Balish
Journal:  FEMS Microbiol Lett       Date:  2012-11-08       Impact factor: 2.742

9.  Mycoplasma orale infection affects K+ and Cl- currents in the HSG salivary gland cell line.

Authors:  K T Izutsu; S Fatherazi; C M Belton; D Oda; F D Cartwright; G E Kenny
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-06       Impact factor: 2.416

10.  Binding of IgA by Mycoplasma penetrans.

Authors:  Awni Moussa; Ran Nir-Paz; Shlomo Rottem
Journal:  Curr Microbiol       Date:  2009-02-03       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.